Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Liver Disease Clinical Trials

A listing of Liver Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (485) clinical trials

To evaluate the pharmacokinetics and safety of copanlisib in subjects with impaired hepatic or renal function in comparison to healthy subjects

Phase

Clinical Trials of Texas, Inc. is enrolling now for an investigational medication for patients with non-alcoholic fatty liver disease. Study participation is approximately 98 days. Qualified participants will receive study-related medical care from a board-certified physician, study medications, exams and evaluations. Qualified participants will help further medical science for treatment ...

Phase N/A

Nonalcoholic fatty liver disease (NAFLD) is liver inflammation caused by a buildup of fat in the liver. Clinsearch Clinical Research is enrolling volunteers with NAFLD in a placebo-controlled study testing an investigational medication. The total duration of a subject’s study participation is between 12 and 35 weeks. Eligibility Criteria: To ...

Phase N/A

This Study will not provide or recommend any treatment or any changes to your standard medical care. If you participate, there will not be any additional doctor visits outside of your standard medical visits to the Cystic Fibrosis Care Centers. Participation in this Study will not require any additional time ...

Phase N/A

To explore the antiviral efficacy of combination therapy with sofosbuvir/ledipasvir fixed-dose combination ribavirin for 12 or 24 weeks in patients with advanced liver disease. Study designed with A cohort and B cohort.

Phase N/A

What is Alpha-1 Antitrypsin Deficiency? Alpha-1 Antitrypsin Deficiency is a genetic (inherited) condition that may result in serious lung disease in adults and/or liver disease at any age. Alpha-1 Antitrypsin Deficiency occurs when there is a lack of a protein in the blood called alpha-1 antitrypsin, or AAT. AAT is ...

Phase N/A

To study the investigational drug, obeticholic acid (also known as OCA), and its effect on NASH and to find out how safe and effective OCA may be in delaying specific medical conditions or health related issues that can occur in patients with NASH and evidence of liver fibrosis. Patients will ...

Phase

Concerned about high blood cholesterol and fatty liver disease? Wake Research Associates is enrolling volunteers in a study of the safety and effectiveness of an investigational drug for hypercholesterolemia and non-alcoholic fatty liver disease (NAFLD).

Phase

A research study is evaluating an investigational medication for Nonalcoholic Fatty Liver Disease (NAFLD).

Phase N/A